Clinical Trials Directory

Trials / Conditions / Ocular Graft-versus-host Disease

Ocular Graft-versus-host Disease

10 registered clinical trials studyying Ocular Graft-versus-host Disease — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA PHASE II PROSPECTIVE RANDOMIZED DOUBLE-MASKED CROSSOVER STUDY ASSESSING THE SAFETY & EFFICACY OF RHPRG4 (450
NCT07118254
Lubris Bio Pty LtdPhase 2
TerminatedRHPRG4 FOR THE TREATMENT OF OCULAR GRAFT-VERSUS-HOST DISEASE (OGVHD)
NCT06495307
Lubris Bio Pty LtdPhase 1 / Phase 2
Not Yet RecruitingValidation of Human Drugs Target of Repurposed Drugs and Novel Therapies
NCT06412718
IRCCS Ospedale San Raffaele—
RecruitingEvaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine i
NCT06348602
Hospital Universitario Dr. Jose E. GonzalezPhase 1 / Phase 2
CompletedThe Effects and Safety of 5% Lifitegrast Ophthalmic Solution in Subjects With Dry Eye Disease in Ocular Graft-
NCT04792580
Richard W Yee, MDEARLY_Phase 1
CompletedEvaluation of the Safety and Effectiveness of omniLenz in Patient With Ocular Graft vs Host Disease
NCT07066865
Farwaniya HospitalN/A
UnknownSafety and Efficacy of Pro-ocular™ 1% in Daily Scleral Lens Wearing Patients With Ocular Graft-versus-Host Dis
NCT04769648
Glia, LLCPhase 2 / Phase 3
CompletedAllogeneic Platelet Lysate Eye Drops for the Treatment of Severe Chronic Ocular Graft-versus-host Disease
NCT05311514
St. Petersburg State Pavlov Medical UniversityPhase 2
WithdrawnVigamox Treatment for Ocular Graft-Versus-Host Disease
NCT04204122
Washington University School of MedicinePhase 2
CompletedStudy for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED
NCT03298815
University of UtahPhase 1 / Phase 2